Updated MRI-Based AI Software Offers Automated Segmentation and Volumetric Reporting of Brain Metastases and Meningiomas
The addition of two new AI-enabled models for the latest version of the NeuroQuant Brain Tumor software facilitates automated tracking of the progression of brain tumors and meningiomas.
Cortechs.ai has launched an updated version of the NeuroQuant Brain Tumor software, which reportedly provides full artificial intelligence (AI)-powered automation for segmentation and volumetric assessment of brain metastases and meningiomas.
The company noted that the NeuroQuant Brain Tumor software has been updated with two new AI-enabled models that facilitate improved neuroradiology workflows and enhanced tracking of the progression of brain metastases and meningiomas.
The updated NeuroQuant Brain Tumor software offers "critical insights into changes in tumor volume over time" for brain metastases and meningiomas, according to Nikdokht Farid, M.D., a professor of neuroradiology at the University of California, San Diego (UCSD). (Image courtesy of Cortechs.ai .)
Nikdokht Farid, M.D., a professor of neuroradiology at the University of California, San Diego (UCSD), said the automated capabilities of the NeuroQuant Brain Tumor software offer significant benefit to neuroradiologists.
"NeuroQuant® Brain Tumor's longitudinal tracking capabilities offer critical insights into changes in tumor volume over time, facilitating more accurate monitoring of treatment response and more informed clinical decision-making. With the latest software release, which offers automated segmentation and tracking of brain metastases and meningiomas, this tool has tremendous potential to improve workflow efficiency and clinical confidence in detecting, measuring, and following brain metastases and meningiomas," said Dr. Farid, the vice president of the American Association for Women in Radiology (AAWR).
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Reducing the Interval Breast Cancer Rate of Screening DBT: Can AI Have an Impact?
July 29th 2025In a retrospective review of screening digital breast tomosynthesis (DBT) exams for over 200 women with interval breast cancers, researchers found that AI provided accurate localization of cancers in 32.6 percent of the cases.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
July 22nd 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.
